Dynamic Technology Lab Private LTD Atara Biotherapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.41 - $2.31 $16,817 - $27,551	11,927 New	11,927 $17,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $96,999 - $297,125	34,035 New	34,035 $129,000
Q2 2021 Aug 13, 2021	SELL	$12.89 - $16.58 $194,703 - $250,440	-15,105 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$14.0 - $20.72 $211,470 - $312,975	15,105 New	15,105 $217,000
Q4 2020 Feb 11, 2021	SELL	$12.67 - $26.23 $199,501 - $413,017	-15,746 Closed	0 $0

Q3 2020 Nov 13, 2020	BUY	$11.92 - $15.87 $187,692 - $249,889	15,746 New	15,746 $204,000
Q3 2018 Nov 14, 2018	SELL	$35.05 - $43.5 $346,013 - $429,432	-9,872 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$35.15 - $51.45 $347,000 - $507,914	9,872 New	9,872 $363,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.